← FDA Drug Approvals (Drugs@FDA)

TAVABOROLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2021-02-08

Drug application

FDA Application #

ANDA212168

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAVABOROLE

Generic name

Tavaborole

Active ingredients

TAVABOROLE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

LUPIN

First approval

2021-02-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown